Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients


Creative Commons License

Hurşitoğlu O., Belge Kurutaş E., Strawbridge R., Oner ., Güngör M., Tuman T. C., ...Daha Fazla

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL, cilt.8, ss.121-129, 2022 (SCI-Expanded)